Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults-Reference-Cited by-同舟云学术

Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Published:2015-08-12 Issue:300 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Green Christopher A.¹,Scarselli Elisa²,Sande Charles J.¹,Thompson Amber J.¹,de Lara Catherine M.³,Taylor Kathryn S.¹,Haworth Kathryn¹,Del Sorbo Mariarosaria²,Angus Brian¹,Siani Loredana²,Di Marco Stefania²,Traboni Cinzia²,Folgori Antonella²,Colloca Stefano²,Capone Stefania²,Vitelli Alessandra²,Cortese Riccardo⁴,Klenerman Paul³,Nicosia Alfredo²⁵⁶,Pollard Andrew J.¹

Affiliation:

1. Oxford Vaccine Group, Department of Paediatrics, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7LE, UK.

2. ReiThera SRL (formerly Okairos SRL), Viale Città d’Europa 679, 00144 Rome, Italy.

3. Experimental Medicine Division, Nuffield Department of Medicine, Peter Medawar Building, University of Oxford, Oxford OX1 3SY, UK.

4. Keires AG, Bäumleingasse 18, 4051 Basel, Switzerland.

5. CEINGE, Via Gaetano Salvatore 486, 80145 Naples, Italy.

6. Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.

Abstract

The RSV vaccine candidates PanAd3-RSV and MVA-RSV were safe and immunogenic in healthy adults.

Funder

Wellcome Trust

ReiThera SRL

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference72 articles.

1. Risk of primary infection and reinfection with respiratory syncytial virus;Glezen W. P.;Am. J. Dis. Child.,1986

2. Trends in Bronchiolitis Hospitalizations in the United States, 2000–2009

3. Viral Etiologies of Infant Bronchiolitis, Croup and Upper Respiratory Illness During 4 Consecutive Years

4. The Burden of Respiratory Syncytial Virus Infection in Young Children

5. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients;Transplantation and Cellular Therapy;2023-12

2. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates;2023-11-22

3. Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study;Science Advances;2023-10-27

4. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections;Pharmaceutical Research;2023-04-25

5. Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models;npj Vaccines;2023-03-23